JP2008513035A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513035A5
JP2008513035A5 JP2007532893A JP2007532893A JP2008513035A5 JP 2008513035 A5 JP2008513035 A5 JP 2008513035A5 JP 2007532893 A JP2007532893 A JP 2007532893A JP 2007532893 A JP2007532893 A JP 2007532893A JP 2008513035 A5 JP2008513035 A5 JP 2008513035A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
modified virus
virus
particle according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007532893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513035A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/054721 external-priority patent/WO2006032674A1/en
Publication of JP2008513035A publication Critical patent/JP2008513035A/ja
Publication of JP2008513035A5 publication Critical patent/JP2008513035A5/ja
Pending legal-status Critical Current

Links

JP2007532893A 2004-09-21 2005-09-21 Ａｐ２０５のコートタンパク質と抗原性ポリペプチドとの融合タンパク質を含んでなるウイルス粒子 Pending JP2008513035A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61130804P 2004-09-21 2004-09-21
EP05105229 2005-06-14
PCT/EP2005/054721 WO2006032674A1 (en) 2004-09-21 2005-09-21 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide

Publications (2)

Publication Number Publication Date
JP2008513035A JP2008513035A (ja) 2008-05-01
JP2008513035A5 true JP2008513035A5 (cg-RX-API-DMAC7.html) 2009-06-18

Family

ID=46307785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532893A Pending JP2008513035A (ja) 2004-09-21 2005-09-21 Ａｐ２０５のコートタンパク質と抗原性ポリペプチドとの融合タンパク質を含んでなるウイルス粒子

Country Status (10)

Country Link
US (1) US20080292652A1 (cg-RX-API-DMAC7.html)
EP (1) EP1791870A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008513035A (cg-RX-API-DMAC7.html)
AU (1) AU2005286475A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0516953A (cg-RX-API-DMAC7.html)
CA (1) CA2580208A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007003171A (cg-RX-API-DMAC7.html)
NZ (1) NZ554387A (cg-RX-API-DMAC7.html)
RU (1) RU2409667C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006032674A1 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
CA2492826C (en) 2001-09-14 2016-12-13 Cytos Biotechnology Ag Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
CN101711865A (zh) * 2002-07-19 2010-05-26 希托斯生物技术股份公司 含有淀粉样β1-6抗原阵列的疫苗组合物
ZA200503511B (en) 2002-10-29 2006-10-25 Coley Pharmaceutical Group Ltd Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
EP1605972A2 (en) * 2003-03-26 2005-12-21 Cytos Biotechnology AG Hiv-peptide-carrier-conjugates
KR20070059207A (ko) 2004-10-05 2007-06-11 사이토스 바이오테크놀로지 아게 Ｖｌｐ-항원 컨쥬게이트 및 백신으로서 그의 용도
WO2006045796A2 (en) 2004-10-25 2006-05-04 Cytos Biotechnology Ag Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof
EP1896068A1 (en) * 2005-06-14 2008-03-12 Cytos Biotechnology AG Antigen conjugates and uses thereof
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
EP1931383A1 (en) 2005-09-28 2008-06-18 Cytos Biotechnology AG Interleukin-1 conjugates and uses thereof
US20070184068A1 (en) * 2005-12-14 2007-08-09 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
EP2530086B1 (en) 2006-06-12 2019-03-20 Kuros Biosciences AG Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
AU2013204383B2 (en) * 2006-06-12 2016-09-22 Kuros Us Llc Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
US20090142362A1 (en) * 2006-11-06 2009-06-04 Avant Immunotherapeutics, Inc. Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
US8586728B2 (en) 2006-12-12 2013-11-19 Cytos Biotechnology Ag Oligonucleotides containing high concentrations of guanine monomers
WO2008074895A1 (en) * 2006-12-21 2008-06-26 Cytos Biotechnology Ag Circular ccr5 peptide conjugates and uses thereof
CN101245110B (zh) * 2007-02-16 2010-09-15 鲁南制药集团股份有限公司 重组中性粒细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
BRPI0910476A2 (pt) * 2008-04-22 2018-03-27 Cytios Biotechnology Ag composições de vacinas para tratamento de febre do dengue e seus usos
WO2010122164A1 (en) 2009-04-23 2010-10-28 Cytos Biotechnology Ag VIRUS-LIKE PARTICLES OF BACTERIOPHAGE φCB5
EP2424570A1 (en) * 2009-04-30 2012-03-07 Cytos Biotechnology AG Influenza hemagglutinin compositions and uses thereof
US20130011431A1 (en) * 2010-03-29 2013-01-10 Novartis Ag Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
GB201121571D0 (en) * 2011-12-15 2012-01-25 Astrimmune Ltd Compounds and uses thereof
JP2015503907A (ja) 2011-12-22 2015-02-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 真核細胞のための全長抗体提示システムおよびその使用
AU2013221187B9 (en) * 2012-02-16 2018-01-04 Vlp Therapeutics, Inc. Virus like particle composition
EP3158058B1 (en) 2014-06-18 2019-04-17 MorphoSys AG Fusion proteins and uses thereof
CN104255335B (zh) * 2014-08-24 2016-08-31 苗建军 一种吊放蔓用钳
RU2568872C1 (ru) * 2014-10-15 2015-11-20 Игорь Геннадьевич Сивов Лекарственное средство для лечения вирусного гепатита с
MA40824A (fr) 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
CA3010975A1 (en) 2015-01-15 2016-07-21 University Of Copenhagen Virus-like particle with efficient epitope display
ES2854726T3 (es) 2015-10-30 2021-09-22 The Univ Of Copenhagen Partícula similar a virus con presentación eficiente de epítopos
WO2017106806A1 (en) * 2015-12-18 2017-06-22 Federica Cavallo COMPOSITIONS AND METHODS RELATED TO xCT PEPTIDES
WO2017186813A1 (en) * 2016-04-27 2017-11-02 Benchmark Animal Health Ltd. Treatment of canine atopic dermatitis
CN112500456B (zh) * 2020-12-02 2022-10-28 深圳赫兹生命科学技术有限公司 一种去势ap205病毒样颗粒亚单位疫苗
WO2022169714A1 (en) * 2021-02-02 2022-08-11 Provaxus, Inc. Novel immunomodulation platform and methods of use
BR112023020640A2 (pt) 2021-04-12 2023-12-05 Saiba AG Partículas similares a vírus de bacteriófago ap205 modificadas
US20240156937A1 (en) * 2021-04-23 2024-05-16 Unm Rainforest Innovations Baceriophage virus-like particles vaccines for chlamydia trachomatis infections
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN115819623A (zh) * 2022-12-12 2023-03-21 长春百克生物科技股份公司 一种重组病毒样颗粒疫苗组合物的制备及应用
CN118684781A (zh) * 2023-03-21 2024-09-24 深圳赫兹生命科学技术有限公司 GnRH-VLP重组去势疫苗及其制备方法
WO2025000310A1 (zh) * 2023-06-29 2025-01-02 深圳赫兹生命科学技术有限公司 去势ap205病毒样颗粒亚单位疫苗的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193565A1 (en) * 1998-03-27 2002-12-19 Stanley Margaret Anne Antigen preparation and use
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7128911B2 (en) * 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
CA2492826C (en) * 2001-09-14 2016-12-13 Cytos Biotechnology Ag Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
US20030091593A1 (en) * 2001-09-14 2003-05-15 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
CN1558774B (zh) * 2001-10-05 2012-03-14 赛托斯生物技术公司 血管紧张肽-载体偶联物及其用途
ATE419007T1 (de) * 2001-11-07 2009-01-15 Cytos Biotechnology Ag Antigenraster welche il-5, il-13 oder eotaxin präsentieren, zur behandlung von allergischen, eosinophilen erkrankungen
DK1441764T3 (da) * 2001-11-07 2009-01-26 Cytos Biotechnology Ag Antigen-Arrays der omfatter RANKL til behandling af knoglesygdom
EP1513552B1 (en) * 2002-06-20 2010-12-01 Cytos Biotechnology AG Packaged virus-like particles in combination with cpg for use as adjuvants with allergens : method of preparation and use
ES2431963T3 (es) * 2002-07-05 2013-11-28 Folia Biotech Inc. Partícula viral adyuvante
RU2324704C2 (ru) * 2002-07-17 2008-05-20 Цитос Байотекнолоджи Аг Молекулярные массивы антигенов

Similar Documents

Publication Publication Date Title
JP2008513035A5 (cg-RX-API-DMAC7.html)
RU2409667C2 (ru) Вирусоподобные частицы, включающие гибридный белок белка оболочки бактериофага ар205 и антигенного полипептида
JP2004522735A5 (cg-RX-API-DMAC7.html)
RU2003125363A (ru) Молекулярный массив антигенов
RU2005104235A (ru) Молекулярные массивы антигенов
KR102775741B1 (ko) Cmv의 변형된 바이러스-유사 입자
Al-Barwani et al. Antigen delivery by virus-like particles for immunotherapeutic vaccination
KR20070058426A (ko) 비-인간 ｔｎｆ-펩티드의 담체 콘쥬게이트의 의학적 용도
JP7623282B2 (ja) 融合によって修飾されたｃｍｖのウイルス様粒子
CA2672826A1 (en) Circular ccr5 peptide conjugates and uses thereof
NZ531534A (en) Angiotensin peptides conjugated with a carrier comprising a virus-like particle
JP2024504566A (ja) 核酸ワクチン
US20080019991A1 (en) Carrier Conjugates Of Tnf-Peptides
RU2417793C2 (ru) Конъюгаты впч-антиген и их применение в качестве вакцин
EP4323397A1 (en) Modified virus-like particles of bacteriophage ap205
WO2024091589A1 (en) Malaria immunogen and methods for using same
Toebes et al. Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7